Detalhe da pesquisa
1.
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study.
Am J Gastroenterol
; 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095692
2.
In moderately to severely active UC, etrasimod increased remission at 12 and 52 wk but increased adverse events.
Ann Intern Med
; 176(7): JC82, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399559
3.
Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial.
Clin Gastroenterol Hepatol
; 20(12): 2858-2867.e5, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276329
4.
Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
Am J Gastroenterol
; 117(10): 1632-1638, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862833
5.
Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease.
J Clin Gastroenterol
; 56(3): e166-e170, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739405
6.
Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
Dig Dis Sci
; 67(6): 1956-1974, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021425
7.
Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.
Dig Dis Sci
; 67(11): 5213-5219, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35244825
8.
Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
Dig Dis Sci
; 67(7): 3148-3157, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34401983
9.
Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
Dig Dis Sci
; 67(7): 3089-3095, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286411
10.
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
Gastroenterology
; 158(3): 515-526.e10, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711925
11.
Novel Negative Pressure Protective Box in Upper Digestive Endoscopy: A Prospective Case Series.
Am J Gastroenterol
; 116(6): 1339-1341, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33734112
12.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(10): 2014-2025, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388143
13.
Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
Dig Dis Sci
; 66(5): 1650-1657, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591969
14.
Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
Dig Dis Sci
; 65(7): 2046-2053, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813132
15.
Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review.
Clin Gastroenterol Hepatol
; 17(7): 1265-1275.e8, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30583048
16.
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Clin Gastroenterol Hepatol
; 17(9): 1680-1713, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853616
17.
Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults.
Vox Sang
; 114(4): 363-373, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30937914
18.
High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.
Dig Dis Sci
; 64(2): 518-523, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446928
19.
A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 63(10): 2695-2702, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29968143
20.
Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.
Dig Dis Sci
; 63(5): 1302-1310, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29243105